Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Depression as a risk factor for dementia: Link is independent of dementia-related brain changes

  • Popping pills to pushing needles: Prescription opioid abuse among young adults in NYC

  • Preterm children do not have an increased risk for dyscalculia, new research suggests

  • Management of anticoagulant-associated intracerebral hemorrhage

  • Benefits of e-cigarettes outweigh harms, current evidence suggests

  • New mapping approach lets scientists zoom in and out as the brain processes sound

  • Insular cortex alterations in mouse models of autism

  • Political attitudes derive from body and mind: 'Negativity bias' explains difference between liberals and conservatives

  • Study of twins discovers gene mutation linked to short sleep duration

  • First grade reading suffers in segregated schools

  •